[1] Schalock RL, Luckasson RA, Shogren KA, et al. The renaming of mental retardation:understanding the change to the term intellectual disability[J]. Intellect Dev Disabil, 2007, 45(2):116- 124.
[2] Shevell M, Ashwal S, Donley D, et al. Practice parameter:evaluation of the child with global developmental delay:report of the Quality Standards Subcommittee of the American Academy of Neurology and The Practice Committee of the Child Neurology Society[J]. Neurology, 2003, 60(3):367-380.
[3] Gmitrowicz A, Kucharska A. Developmental disorders in the fourth edition of the American classification:diagnostic and statistical manual of mental disorders (DSM IV-optional book)[J]. Psychiatr Pol, 1994, 28(5):509-521.
[4] van Bokhoven H. Genetic and epigenetic networks in intellectual disabilities[J]. Annu Rev Genet, 2011, 45:81-104.
[5] Moeschler JB, Shevell M. Comprehensive evaluation of the child with intellectual disability or global developmental delays[J]. Pediatrics, 2014, 134(3):e903-918.
[6] Guo L. Etiological analysis of neurodevelopmental disabilities:single-center eight-year clinical experience in south China[J]. J Biomed Biotechnol, 2011, 2011(doi:10.1155/2011/318616).
[7] Economic costs associated with mental retardation, cerebral palsy, hearing loss, and vision impairment-United States, 2003[J]. MMWR Morb Mortal Wkly Rep, 2004, 53(3):57-59.
[8] Gilissen C, Hehir-Kwa JY, Thung DT, et al. Genome sequencing identifies major causes of severe intellectual disability[J]. Nature, 2014, 511(7509):344-347.
[9] de Ligt J, Willemsen MH, van Bon BW, et al. Diagnostic exome sequencing in persons with severe intellectual disability[J]. N Engl J Med, 2012, 367(20):1921-1929.
[10] Rauch A, Wieczorek D, Graf E, et al. Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability:an exome sequencing study[J]. Lancet, 2012, 380(9854):1674-1682.
[11] Musante L, Ropers HH. Genetics of recessive cognitive disorders[J]. Trends Genet, 2014, 30(1):32-39.
[12] Flint J, Wilkie AO, Buckle VJ, et al. The detection of subtelomeric chromosomal rearrangements in idiopathic mental retardation[J]. Nat Genet, 1995, 9(2):132-140.
[13] Wu Y, Ji T, Wang J, et al. Submicroscopic subtelomeric aberrations in Chinese patients with unexplained developmental delay/mental retardation[J]. BMC Med Genet, 2010, 11:72.
[14] Shao L, Shaw CA, Lu XY, et al. Identification of chromosome abnormalities in subtelomeric regions by microarray analysis:a study of 5,380 cases[J]. Am J Med Genet A, 2008, 146A(17):2242-2251.
[15] Knight SJ, Regan R, Nicod A, et al. Subtle chromosomal rearrangements in children with unexplained mental retardation[J]. Lancet, 1999, 354(9191):1676-1681.
[16] Sagoo GS, Butterworth AS, Sanderson S, et al. Array CGH in patients with learning disability (mental retardation) and congenital anomalies:updated systematic review and metaanalysis of 19 studies and 13,926 subjects[J]. Genet Med, 2009, 11(3):139-146.
[17] Hochstenbach R, van Binsbergen E, Engelen J, et al. Array analysis and karyotyping:workflow consequences based on a retrospective study of 36,325 patients with idiopathic developmental delay in the Netherlands[J]. Eur J Med Genet, 2009, 52(4):161-169.
[18] Verkerk AJ, Pieretti M, Sutcliffe JS, et al. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome[J]. Cell, 1991, 65(5):905-914.
[19] Christodoulou J, Ho G. MECP2-Related Disorders[M]. GeneReviews(R), 2012, Seattle (WA).
[20] Lubs HA, Stevenson RE, Schwartz CE. Fragile X and X-linked intellectual disability:four decades of discovery[J]. Am J Hum Genet, 2012, 90(4):579-590.
[21] Hamamy HA, Masri AT, Al-Hadidy AM, et al. Consanguinity and genetic disorders Profile from Jordan[J]. Saudi Med J, 2007, 28(7):1015-1017.
[22] Miller DT, Adam MP, Aradhya S, et al. Consensus statement:chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies[J]. Am J Hum Genet, 2010, 86(5):749-764.
[23] Schaaf CP, Wiszniewska J, Beaudet AL. Copy number and SNP arrays in clinical diagnostics[J]. Annu Rev Genomics Hum Genet, 2011, 12:25-51.
[24] Hook EB. Exclusion of chromosomal mosaicism:tables of 90%, 95% and 99% confidence limits and comments on use[J]. Am J Hum Genet, 1977, 29(1):94-97.
[25] Conlin LK, Thiel BD, Bonnemann CG, et al. Mechanisms of mosaicism, chimerism and uniparental disomy identified by single nucleotide polymorphism array analysis[J]. Hum Mol Genet, 2010, 19(7):1263-1275.
[26] Flore LA, Milunsky JM. Updates in the genetic evaluation of the child with global developmental delay or intellectual disability[J]. Semin Pediatr Neurol, 2012, 19(4):173-180.
[27] Ellison JW, Ravnan JB, Rosenfeld JA, et al. Clinical utility of chromosomal microarray analysis[J]. Pediatrics, 2012, 130(5):e1085-1095.
[28] Girirajan S, Rosenfeld JA, Cooper GM, et al. A recurrent 16p12.1 microdeletion supports a two-hit model for severe developmental delay[J]. Nat Genet, 2010, 42(3):203-209.
[29] Vissers LE, de LJ, Gilissen C, et al. A de novo paradigm for mental retardation[J]. Nat Genet, 2010, 42(12):1109-1112.
[30] BCABS Association. Special report:exome sequencing for clinical diagnosis of patients with suspected genetic disorders[J]. Technol Eval Cent Assess Program Exec Summ, 2013, 28(3):1-4.
[31] Biesecker LG, Green RC. Diagnostic clinical genome and exome sequencing[J]. N Engl J Med, 2014, 371(12):1170.
[32] Srivastava S, Cohen JS, Vernon H, et al. Clinical whole exome sequencing in child neurology practice[J]. Ann Neurol, 2014, 76(4):473-483.
[33] Engbers HM, Berger R, van HP, et al. Yield of additional metabolic studies in neurodevelopmental disorders[J]. Ann Neurol, 2008, 64(2):212-217.
[34] Lion-Francois L, Cheillan D, Pitelet G, et al. High frequency of creatine deficiency syndromes in patients with unexplained mental retardation[J]. Neurology, 2006, 67(9):1713-1714.
[35] van Karnebeek CD, Shevell M, Zschocke J, et al. The metabolic evaluation of the child with an intellectual developmental disorder:diagnostic algorithm for identification of treatable causes and new digital resource[J]. Mol Genet Metab, 2014, 111(4):428-438.
[36] van Karnebeek CD, Stockler S. Treatable inborn errors of metabolism causing intellectual disability:a systematic literature review[J]. Mol Genet Metab, 2012, 105(3):368-381.